Trials / Completed
CompletedNCT00653822
A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single Dose Study to Assess the Tolerability, Safety, and Pharmacokinetics of Alefacept in Caucasian and Japanese Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to compare the pharmacokinetic and pharmacodynamic properties and safety profile of alefacept in Caucasian and Japanese healthy subjects
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | alefacept | IC and SC |
| DRUG | placebo | IV and SC |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2008-07-01
- Completion
- 2008-07-01
- First posted
- 2008-04-07
- Last updated
- 2013-02-28
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00653822. Inclusion in this directory is not an endorsement.